GB0412262D0 - Use of compounds for the treatment of pain - Google Patents

Use of compounds for the treatment of pain

Info

Publication number
GB0412262D0
GB0412262D0 GB0412262A GB0412262A GB0412262D0 GB 0412262 D0 GB0412262 D0 GB 0412262D0 GB 0412262 A GB0412262 A GB 0412262A GB 0412262 A GB0412262 A GB 0412262A GB 0412262 D0 GB0412262 D0 GB 0412262D0
Authority
GB
United Kingdom
Prior art keywords
pain
compounds
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0412262A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cambridge Biotechnology Ltd
Original Assignee
Cambridge Biotechnology Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cambridge Biotechnology Ltd filed Critical Cambridge Biotechnology Ltd
Priority to GB0412262A priority Critical patent/GB0412262D0/en
Publication of GB0412262D0 publication Critical patent/GB0412262D0/en
Priority to EA200800538A priority patent/EA014425B1/en
Priority to PCT/GB2005/000800 priority patent/WO2005084653A2/en
Priority to EA200601642A priority patent/EA011099B1/en
Priority to EP05717878A priority patent/EP1749016A2/en
Priority to BRPI0508488-1A priority patent/BRPI0508488A/en
Priority to AU2005218997A priority patent/AU2005218997B2/en
Priority to JP2007501345A priority patent/JP2007526291A/en
Priority to NZ549235A priority patent/NZ549235A/en
Priority to US10/598,520 priority patent/US20080221060A1/en
Priority to MXPA06010075A priority patent/MXPA06010075A/en
Priority to SG200804350-7A priority patent/SG144146A1/en
Priority to KR1020067020304A priority patent/KR20070004792A/en
Priority to CA002557285A priority patent/CA2557285A1/en
Priority to IL177721A priority patent/IL177721A0/en
Priority to NO20064365A priority patent/NO20064365L/en
Priority to JP2011280200A priority patent/JP2012102114A/en
Ceased legal-status Critical Current

Links

GB0412262A 2004-03-05 2004-06-02 Use of compounds for the treatment of pain Ceased GB0412262D0 (en)

Priority Applications (17)

Application Number Priority Date Filing Date Title
GB0412262A GB0412262D0 (en) 2004-06-02 2004-06-02 Use of compounds for the treatment of pain
CA002557285A CA2557285A1 (en) 2004-03-05 2005-03-04 Adenosine receptor agonists
NZ549235A NZ549235A (en) 2004-03-05 2005-03-04 Adenosine receptor agonists
MXPA06010075A MXPA06010075A (en) 2004-03-05 2005-03-04 Therapeutic compounds.
EA200601642A EA011099B1 (en) 2004-03-05 2005-03-04 Therapeutic compounds
EP05717878A EP1749016A2 (en) 2004-03-05 2005-03-04 Adenosine receptor agonists
BRPI0508488-1A BRPI0508488A (en) 2004-03-05 2005-03-04 therapeutic compounds
AU2005218997A AU2005218997B2 (en) 2004-03-05 2005-03-04 Adenosine receptor agonists
JP2007501345A JP2007526291A (en) 2004-03-05 2005-03-04 Adenosine receptor agonist
EA200800538A EA014425B1 (en) 2004-03-05 2005-03-04 Therapeutic compounds
US10/598,520 US20080221060A1 (en) 2004-03-05 2005-03-04 Therapeutic Compounds
PCT/GB2005/000800 WO2005084653A2 (en) 2004-03-05 2005-03-04 Adenosine receptor agonists
SG200804350-7A SG144146A1 (en) 2004-03-05 2005-03-04 Adenosine receptor agonists
KR1020067020304A KR20070004792A (en) 2004-03-05 2005-03-04 Adenosine receptor agonists
IL177721A IL177721A0 (en) 2004-03-05 2006-08-28 Adenosine receptor agonists
NO20064365A NO20064365L (en) 2004-03-05 2006-09-26 Therapeutic compound
JP2011280200A JP2012102114A (en) 2004-03-05 2011-12-21 Adenosine receptor agonist

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0412262A GB0412262D0 (en) 2004-06-02 2004-06-02 Use of compounds for the treatment of pain

Publications (1)

Publication Number Publication Date
GB0412262D0 true GB0412262D0 (en) 2004-07-07

Family

ID=32696511

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0412262A Ceased GB0412262D0 (en) 2004-03-05 2004-06-02 Use of compounds for the treatment of pain

Country Status (1)

Country Link
GB (1) GB0412262D0 (en)

Similar Documents

Publication Publication Date Title
EP1744751A4 (en) Methods for the treatment of synucleinopathies
EP1809265A4 (en) Methods for the treatment of synucleinopathies
GB0522311D0 (en) Pharmaceutical compositions for the treatment of pain
AP2007004157A0 (en) N- (N-sulfonylaminomethyl) cyclo-propanecarboxamide derivatives useful for the treatment of pain
IL178827A0 (en) Use of reboxetine for the treatment of pain
GB0329874D0 (en) Compounds useful for the treatment of diseases
PL1945243T3 (en) Use of calcitonin for the treatment of ra
EP1732549A4 (en) Methods for the treatment of synucleinopathies
GB0305150D0 (en) Use of therapeutic compounds
IL187405A0 (en) Methods and compositions for the treatment of pain
EP2007790A4 (en) Compounds and methods for the treatment of pain
IL192933A0 (en) Benzoisoindole derivatives for the treatment of pain
TWI350753B (en) 1-[2h-1-benzopyran-2-one-8-yl]-piperazine derivatives for the treatment of pain
GB0415181D0 (en) Compounds for use in the treatment of infection
GB0400802D0 (en) Compounds for the treatment of disease
IL178907A0 (en) Use of sulglicotide for the treatment of mucositis
EP1719514A4 (en) Drug for treating pain
GB0425854D0 (en) Therapeutic treatment
ZA200606780B (en) Compounds for the treatment of diseases
ZA200710476B (en) Methods and compositions for the treatment of pain
HK1087027A1 (en) Use of 2H-Ä1, 3Ü-oxazinoÄ3,2-AÜindole derivatives for the treatment of neuropathic pain
EP1900363A4 (en) Therapeutic agent for pain
GB0412262D0 (en) Use of compounds for the treatment of pain
GB0418556D0 (en) The treatment of pain
GB0415267D0 (en) The treatment of pain

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)